CCRM Australia and GlobalData Healthcare re agreement

February 28, 2022 (Melbourne, Australia) — The Centre for Commercialisation of Regenerative Medicine Australia (CCRM Australia) has reached an agreement with GlobalData to access the significant resources available through GlobalData for the newly established CCRM Australia Clarity Unit to further accelerate the development of the Australian regenerative medicine sector.

GlobalData Healthcare is internationally recognized as a data provider to the world’s largest industries, continuously collecting and analysing terabytes of data to create the most comprehensive, authoritative, and granular market intelligence.

“CCRM Australia is delighted to partner with GlobalData says Silvio Tiziani, CEO of CCRM Australia. Access to the significant healthcare market data and insights available through GlobalData will provide significant additional benefit to the work of our Clarity Unit.

We look forward to working with the GlobalData team on a range of CCRM Australia Clarity projects to deliver even more value to our partner network and to the Australian regenerative medicine sector.

GlobalData’s Healthcare Director, APAC Glenn Sprowell said ”It is our absolute pleasure to grow the support we already provide Australia’s regenerative medicine sector through this new partnership with Silvio and his fantastic team at CCRM Australia. Regenerative medicine is such an exciting space with such massive potential that could be game-changing for Australian patients.”

About CCRM Australia Clarity

CCRM Australia Clarity is a multi-disciplinary think tank with market research and reporting mission to accumulate thought leadership and analysis to facilitate the commercialisation and diffusion of regenerative medicine into the healthcare sector.  CCRM Australia Clarity activities include but are not limited to:

  • researching and developing regenerative medicine business models and the diffusion of regenerative medicine technologies into the local and global healthcare sector
  • curating industry and research sector data to support the development of new policies and strategies concerning Australia and international markets
  • analysing clinical and social information that help support funding, grant applications and business strategies
  • developing and writing opinion and blog articles for publication in appropriate print and online publications

The Clarity Unit’s interdisciplinary, multi-institutional, demand-driven and team-based approach is fundamental to tackling problems that transcend disciplinary boundaries.

About CCRM Australia

CCRM Australia is an Australian not-for-profit organisation supporting the development of foundational technologies to accelerate the commercialisation of regenerative medicine products and therapies. CCRM Australia’s focus is to bridge the commercialisation gap through a network of scientists, entrepreneurs, academic institutions and industry partners and address bottlenecks in the industry. CCRM Australia is modelled on the highly successful CCRM in Canada and is legally separate from CCRM. As a Global CCRM network member, CCRM Australia partners with a leading-edge industry consortium. MTPConnect and the Victorian State Government support CCRM Australia. Visit for more information.

About GlobalData

The world is becoming more complex, uncertain, and fast-moving than ever before, which is why GlobalData exists. Our mission is to help our clients decode the future to be more successful and innovative. We create trusted intelligence on the world’s largest industries by leveraging our unique data, expert analysis, and innovative solutions.

Easily-accessible and fully-integrated into one platform, our Intelligence Center solution helps companies, government organisations, and industry professionals make faster, more informed decisions. Visit for more information.

For more information, please contact:

CCRM Australia:

Silvio Tiziani, Chief Executive Officer


GlobalData Plc:

For general enquiries regarding our business please contact:

Ramon Rosati, Commercial Director, Industrial and Life Sciences APAC